[HTML][HTML] Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
E Novy, C Roger, JA Roberts, MO Cotta - Critical Care, 2023 - Springer
Intra-abdominal candidiasis (IAC) is one of the most common of invasive candidiasis
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
[引用][C] Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
E Novy, C Roger, JA Roberts, MO Cotta - Critical Care, 2023 - espace.library.uq.edu.au
Intra-abdominal candidiasis (IAC) is one of the most common of invasive candidiasis
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
E Novy, C Roger, JA Roberts… - Critical care (London …, 2023 - pubmed.ncbi.nlm.nih.gov
Intra-abdominal candidiasis (IAC) is one of the most common of invasive candidiasis
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
E Novy, C Roger, JA Roberts, MO Cotta - Critical Care, 2023 - search.proquest.com
Intra-abdominal candidiasis (IAC) is one of the most common of invasive candidiasis
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis.
E Novy, C Roger, JA Roberts, MO Cotta - Critical Care, 2023 - go.gale.com
Intra-abdominal candidiasis (IAC) is one of the most common of invasive candidiasis
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis.
E Novy, C Roger, JA Roberts, MO Cotta - Critical Care, 2023 - search.ebscohost.com
Intra-abdominal candidiasis (IAC) is one of the most common of invasive candidiasis
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
[HTML][HTML] Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
E Novy, C Roger, JA Roberts, MO Cotta - Critical Care, 2023 - ccforum.biomedcentral.com
Intra-abdominal candidiasis (IAC) is one of the most common of invasive candidiasis
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
[HTML][HTML] Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
E Novy, C Roger, JA Roberts, MO Cotta - Critical Care, 2023 - ncbi.nlm.nih.gov
Intra-abdominal candidiasis (IAC) is one of the most common of invasive candidiasis
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
E Novy, C Roger, J Roberts, MO Cotta - Critical Care, 2023 - hal.univ-lorraine.fr
Intra-abdominal candidiasis (IAC) is one of the most common of invasive candidiasis
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis.
E Novy, C Roger, JA Roberts… - Critical Care (London …, 2023 - europepmc.org
Intra-abdominal candidiasis (IAC) is one of the most common of invasive candidiasis
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …
observed in critically ill patients. It is associated with high mortality, with up to 50% of deaths …